Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
NRIX holding history
Nurix Therapeutics, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NRIX overviewAll 13F holders of NRIXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −2,706−100.0% | Sold out | Holders |
| Q4 2024 | 2,706 | $51.0K | <0.1% | −515−16.0% | Reduced | Holders |
| Q3 2024 | 3,221 | $72.4K | <0.1% | −408−11.2% | Reduced | Holders |
| Q2 2024 | 3,629 | $75.7K | <0.1% | −1,154−24.1% | Reduced | Holders |
| Q1 2024 | 4,783 | $70.3K | <0.1% | −689−12.6% | Reduced | Holders |
| Q4 2023 | 5,472 | $56.5K | <0.1% | −288−5.0% | Reduced | Holders |
| Q3 2023 | 5,760 | $45.3K | <0.1% | −19−0.3% | Reduced | Holders |
| Q2 2023 | 5,779 | $57.7K | <0.1% | −1,301−18.4% | Reduced | Holders |
| Q1 2023 | 7,080 | $62.9K | <0.1% | −441−5.9% | Reduced | Holders |
| Q4 2022 | 7,521 | $82.6K | <0.1% | +7,521 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −7,970−100.0% | Sold out | Holders |
| Q4 2021 | 7,970 | $231.0K | <0.1% | −526−6.2% | Reduced | Holders |
| Q3 2021 | 8,496 | $255.0K | <0.1% | +8,496 | New | Holders |